128 related articles for article (PubMed ID: 3288044)
1. The therapeutic potential of lymphokines in neoplastic disease.
Pulley MS; Dumonde DC
Ann N Y Acad Sci; 1988; 521():274-89. PubMed ID: 3288044
[No Abstract] [Full Text] [Related]
2. In vivo enhancement of antitumor immunity by interleukin 2-rich lymphokines.
O'Donnell RW; Marquis DM; Mudholkar GS; McCune CS
Cancer Res; 1986 Jul; 46(7):3273-8. PubMed ID: 3011244
[TBL] [Abstract][Full Text] [Related]
3. [Use of interleukin-2 (proleukin, aldesleukin) in oncological practice].
Gershanovich ML
Vopr Onkol; 2003; 49(6):776-82. PubMed ID: 14976930
[No Abstract] [Full Text] [Related]
4. Lymphokines and cytokines as cancer treatment. Immunotherapy realized.
Borden EC; Sondel PM
Cancer; 1990 Feb; 65(3 Suppl):800-14. PubMed ID: 2406003
[TBL] [Abstract][Full Text] [Related]
5. [Effects of interleukin-2 and lymphokine-activated killer cells on cell cultures and on transplanted tumors (nude mouse) of human pancreatic carcinomas].
Kühl JS; Klapdor R; Bahlo M; Arps H; Dietel M; Mohr M
Beitr Infusionther Klin Ernahr; 1987; 18():261-5. PubMed ID: 3501948
[No Abstract] [Full Text] [Related]
6. Lymphokines and cytokines.
Wagstaff J; Melief K
Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
[No Abstract] [Full Text] [Related]
7. Molecular engineering of the antitumor immune response.
Pardoll DM; Golumbek P; Levitsky H; Jaffee L
Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
[No Abstract] [Full Text] [Related]
8. Lymphokines and cytokines.
Wagstaff J; Melief KJ
Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
[TBL] [Abstract][Full Text] [Related]
9. Antitumor therapy and IL-2.
Gunby P
JAMA; 1981 Jul; 246(3):205, 209. PubMed ID: 6972457
[No Abstract] [Full Text] [Related]
10. Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells.
Rosenberg SA
Important Adv Oncol; 1988; ():217-57. PubMed ID: 3042605
[No Abstract] [Full Text] [Related]
11. [Expectations in the clinical application of human-recombinant cytokines. 2) Clinical trials of IL-2].
Ohe Y; Saijo N
Nihon Rinsho; 1988 May; 46(5):1093-8. PubMed ID: 3045365
[No Abstract] [Full Text] [Related]
12. On lymphokines, cytokines, and breakthroughs.
Moertel CG
JAMA; 1986 Dec; 256(22):3141. PubMed ID: 3537345
[No Abstract] [Full Text] [Related]
13. Lymphokines and cytokines.
Wagstaff J
Cancer Chemother Biol Response Modif; 1991; 12():165-92. PubMed ID: 1718375
[No Abstract] [Full Text] [Related]
14. Interleukin 2 and lymphokine-activated killer cells in the treatment of childhood primary hepatocellular carcinoma--a preliminary report.
Hsieh KH; Chang JS; Wu HL; Chu CT
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):13-6. PubMed ID: 3040030
[TBL] [Abstract][Full Text] [Related]
15. Rationale and therapeutic basis for patients receiving recombinant interleukin-2.
Dudjak LA
Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):3-7. PubMed ID: 8210792
[No Abstract] [Full Text] [Related]
16. Genetech enlightens other angiogenesis programs.
Brower V
Nat Biotechnol; 1999 Apr; 17(4):326-7. PubMed ID: 10207873
[No Abstract] [Full Text] [Related]
17. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Rosenberg SA
Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
[No Abstract] [Full Text] [Related]
18. Proceedings of the second meeting of the IUIS Lymphokine Standardization Subcommittee. March 5 and 8, 1986, Erlangen, West Germany.
Lymphokine Res; 1986; 5 Suppl 1():S1-192. PubMed ID: 3537546
[No Abstract] [Full Text] [Related]
19. Lymphokines and cytokines.
Wagstaff J
Cancer Chemother Biol Response Modif; 1990; 11():204-34. PubMed ID: 1699586
[No Abstract] [Full Text] [Related]
20. [Intrapleural instillation of recombinant IL-2 in a patient with pleuritis carcinomatosa].
Kimura H; Yamaguchi Y; Iwai N; Kashiwaya A; Yamakawa H; Baba M; Fujisawa T
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1580-4. PubMed ID: 3263452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
